Propanc Biopharma, Inc. Common Stock

PPCBNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
3.01 USD
↗ 1.66 (123.19%)🟢LIVE (AS OF 02:20 PM EDT)
🟢Market: OPEN

PPCB is currently priced at $3.01. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Jun 10, 2026.

Open?$3.21
High?$6.50
Low?$1.40
Prev. Close?$1.35
Volume?161.9M
Avg. Volume?458.7K
VWAP?$4.79
Rel. Volume?353.05x
Bid / Ask
Bid?$2.69 × 100
Ask?$3.56 × 100
Spread?$0.87
Midpoint?$3.13
Valuation & Ratios
Market Cap?3.1M
Shares Out?2.3M
Float?14.9M
Float %?71.5%
P/E Ratio?N/A
P/B Ratio?0.31
EPS?-$8.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Themes
Healthcare - Oncology›Targeted Therapy & Precision OncologyBiotech - Drug Development›Clinical-Stage Platforms
Employees
2
Market Cap
3.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.propanc.com
Listed
2012-06-15
Address
302/6 BUTLER STREET
CAMBERWELL, VICTORIA, C3 3124
Phone: 61-03-9882-0780
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.21%Low
Short Interest?31.2K
Days to Cover?1.0
Free Float14.9M
Avg Daily Volume90.3K
Settlement Date2026-05-29
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?0.13Low
Debt/Equity?0.07Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.31CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-196.3%WEAK▾
ROA?
S&P
3
-134.6%WEAK▾
Cash Flow & Enterprise
FCF?$-4112751
Enterprise Value?$3.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist